Basic info
Industry
biotechnology research
Sectors
Biotechnology
drug development
Life Science
cell atlases
RNA Imaging in situ
immunology
spatially-resolved RNA profiling
transcriptomics
high resolution
high throughput
single cell genomics
translational research
multi-omics
high accuracy
cancer research
spatial gene expression
spatial genomics research
Health Care
high multiplexing
Human Cell Atlas
single cell gene expression
neuroscience
Medical
in situ single-cell omics
Date founded
2019
Funding rounds raised
Total raised
$85M
from 12 investors over 12 rounds
V
Vizgen raised $85M on June 3, 2022
Investors: Sofina, Tao Capital Partners, Northpond Ventures, ARCH Venture Partners and Novalis LifeSciences LLC
V
Vizgen raised $37M on April 7, 2021
Investors: Novalis LifeSciences LLC, Pura Vida Investments, ARCH Venture Partners, Tao Capital Partners and Northpond Ventures
V
Vizgen raised $14M on January 30, 2020
Investors: ARCH Venture Partners and Northpond Ventures